Announcements Trials
Browse Landscape

Phase

Phase 3 18Phase 2 18Phase EARLY_PHASE1 2Phase 4 2Phase 1 2Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Denosumab × Clear all
NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
10 enrolled
Breast

Breast Neoplasms

NCT02900469 2020-08-21

Presurgical Trial of Denosumab in Breast Cancer

NYU Langone Health

Phase EARLY_PHASE1 Completed
44 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡